Catalyst Wire Dossier Catalyst Wire Dossier

Enlicitide Chloride

MK-0616 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Enlicitide Chloride, covering 2024-09-26 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010) [Phase 1]

See pricing